High-mannose glycans are elevated during breast cancer progression

Molecular and Cellular Proteomics

Volumn 10, Issue 1, 2011, Pages

  De Leoz, Maria Lorna A ^a   Young, Lawrence J T ^a   An, Hyun Joo ^a   Kronewitter, Scott R ^a   Kim, Jaehan ^a   Miyamoto, Suzanne ^b   Borowsky, Alexander D ^a   Chew, Helen K ^b   Lebrilla, Carlito B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN DERIVATIVE; MANNOSE; VIRUS MIDDLE T ANTIGEN; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER GROWTH; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN GLYCOSYLATION; ANIMAL; BLOOD; BREAST TUMOR; CHEMISTRY; CONFORMATION; DISEASE COURSE; MASS SPECTROMETRY; METASTASIS; PATHOLOGY;

MOUSE MAMMARY TUMOR VIRUS; MUS;

ANIMALS; BREAST NEOPLASMS; CARBOHYDRATE CONFORMATION; DISEASE PROGRESSION; FEMALE; HUMANS; MANNOSE; MICE; NEOPLASM METASTASIS; POLYSACCHARIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 78651063463     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M110.002717-1     Document Type: Article

References (39)

1. Garcia, M. J. A., et al. (2007) Global Cancer Facts and Figures 2007. American. Cancer Society, Atlanta, GA
2. Jemal, A., Siegel, R., Xu, J., and Ward, E. (2010) Cancer Statistics, 2010. CA Cancer J. Clin. 60, 277-300
3. Harris, L., et al. (2007) American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J. Clin. Oncol. 25, 5287-5312 (Pubitemid 350232263)
4. Safi, F., Kohler, I., Röttinger, E. and Beger, H. (1991) The value of the tumor marker CA 25-3 in diagnosing and monitoring breast cancer: A comparative study with carcinoembryonic antigen. Cancer 68, 574-582
5. Seregni, E., Coli, A., and Mazzucca, N. (2004) Circulating tumour markers in breast cancer. Eur. J. Nucl. Med.Mol. Imaging 31, 515-522
6. Stearns, V., Yamauchi, H., and Hayes, D. F. (1998) Circulating tumor markers in breast cancer: Accepted utilities and novel prospects. Breast Cancer Res. Trends 52, 239-259
7. Guadagni, F., et al. (2001) A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: A prospective longitudinal study. Clin. Cancer Res. 7, 2357-2362
8. Brooks, S. A., Dwek, M. V. and Schumacher, U. (2002) Functional and molecular glycobiology , BIOS Scientific Publishers Ltd, Oxford, UK
9. Varki, A., et al. (2009) Essentials of glycobiology, 2nd Ed. Cold Spring Harbor Laboratory Press, New York
10. Abd, Hamid, U. M., et al. (2008) A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology 18, 1105-1118
11. Kyselova, Z., et al. (2008) Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin. Chem. 54, 1166-1175
12. Alley, W. R., Madera, M., Mechref, Y., and Novotny, M. V. (2010) Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: A potential methodology for cancer-biomarker discovery. Anal. Chem. 82, 5095-5106
13. An, H. J., Kronewitter, S. R., de, Leoz, M. L., and Lebrilla, C. B. (2009) Glycomics and disease markers. Current Opinion Chem. Biol. 13, 601-607
14. Kirmiz, C., et al. (2007) A serum glycomics approach to breast cancer biomarkers. Mol. Cellular Proteomics 6, 43-55
15. Maglione, J. E., et al. (2001) Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Res. 61, 8298-8305
16. Maglione, J. E., et al. (2004) Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: Single origin, divergent evolution, and multiple outcomes. Mol. Cancer Ther. 3, 941-953
17. Jessen, K. A., et al. (2004) Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin. Breast Cancer Res. 6, R157-R169
18. de, Leoz, M. L., et al. (2008) Glycomic approach for potential biomarkers on prostate cancer: Profiling of N-linked glycans in human sera and pRNS cell lines. Disease Markers 25, 243-258
19. Kronewitter, S. R., et al. (2010) Human serum processing and analysis methods for rapid and reproducible N-glycan mass profiling. J. Proteome Res. 9, 4952-4959
20. An, H. J., et al. (2006) Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J. Proteome Res. 5, 1626-1635 (Pubitemid 44043097)
21. Kyselova, Z., et al. (2007) Alterations in the serum glycome due to metastatic prostate cancer. J. Proteome Res. 6, 1822-1832
22. Kita, Y., et al. (2007) Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N-glycans. Mol. Cell. Proteomics 6, 1437-1445
23. Morelle, W., et al. (2006) Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis. Glycobiology 16, 281-293
24. Kam, R. K., et al. (2007) High-throughput quantitative profiling of serum N-glycome by MALDI-TOF mass spectrometry and N-glycomic fingerprint of liver fibrosis. Clin. Chem. 53, 1254-1263
25. Kronewitter, S. R., et al. (2009) The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome. Proteomics 9, 2986-2994
26. Chu, C. S., et al. (2009) Profile of native N-linked glycan structures from human serum using high performance liquid chromatography on a microfluidic chip and time-of-flight mass spectrometry. Proteomics 9, 1939-1951
27. An, H. J., Tillinghast, J. S., Woodruff, D. L., Rocke, D. M., and Lebrilla, C. B. (2006) A new computer program (GlycoX) to determine simultaneously the glycosylation sites and oligosaccharide heterogeneity of glycoproteins. J. Proteome Res. 5, 2800-2808
28. Van, Oss, C. J. (1989) On the Mechanism of the Cold Ethanol Precipitation Method of Plasma-Protein Fractionation. J. Protein Chem. 8, 661-668
29. Lattova, E., Varman, S., Bezabeh, T., Petrus, L., and Perrault, H. (2008) Mass spectrometric profiling of N-linked oligosaccharides and uncommon glycoform in mouse serum with head and neck tumor. J.Am. Soc. Mass Spectr. 19, 671-685
30. Vanhooren, V., et al. (2007) N-glycomic changes in serum proteins during human aging. Rejuvenation Res. 10, 521-531
31. Vanhooren, V., Laroy, W., Libert, C., and Chen, C. (2008) N-Glycan profiling in the study of human aging. Biogerontology 9, 351-356
32. Goetz, J. A., Mechref, Y., Kang, P., Jeng, M. H., and Novotny, M. V. (2009) Glycomic profiling of invasive and non-invasive breast cancer cells. Glycoconjugate J. 26, 117-131
33. Johns, T. G., et al. (2005) The antitumor monoclonal antibody 806 recognizes a high-mannose form of the EGF receptor that reaches the cell surface when cells over-express the receptor. FASEB J. 19(3):780-782
34. Yamaguchi, H., and Uchida, M. (1996) A chaperone-like function of intramolecular high-mannose chains in the oxidative refolding of bovine pancreatic RNase B. J.Biochem. 120, 474-477
35. Morishima, S., et al. (2003) Expression and role of mannose receptor/terminal high-mannose type oligosaccharide on osteoclast precursors during osteoclast formation. J. Endocrinol. 176, 285-292
36. Driouich, A., Gonnet, P., Makkie, M., Laine, A.-c, and Faye, L. (1989) The role of high-mannose and complex asparagine-linked glycans in the secretion and stability of glycoproteins. Planta 180, 96-104
37. Vagin, O., Kraut, J. A., and Sachs, G. (2009) Role of N-glycosylation in trafficking of apical membrane proteins in epithelia. Am. J. Physiol. Renal Physiol. 296, 459-469
38. Helenius, A., and Aebi, M. (2001) Intracellular functions of N-linked glycans. Science 291, 2364-2369
39. Varki, A., et al. (2009) Symbol nomenclature for glycan representation. Proteomics 9, 5398-5399